Refocusing Hepatitis C Prevention Through Geographic Viral Load Analyses

Approximately 2.7 million Americans live with chronic HCV, with roughly 30,000 new cases in 2013. Fortunately, recent clinical trials have shown great advances using interferon-free, oral direct-acting antivirals, with cure rates over 95% . But only a few people have been treated, and most are unaware of the infection. This presents an opportunity for public health to address unmet needs, but most jurisdictions have limited surveillance and prevention efforts. Leveraging HCV surveillance, this analysis presents a cost-effective method to improve situational awareness and guide prevention efforts in Houston.

Objective

To describe the use of Hepatitis C Virus (HCV) viral load (VL) results and geospatial analysis to guide prevention efforts.